87000EGP
- Active ingredient
- zanubrutinib
- Strength
- 80mg
- Form
- capsule
- Manufacturer
- ramco
- Route
- oral.solid
Uses
Used for the treatment of selected B-cell malignancies including certain lymphomas and chronic lymphocytic leukemia.
Do not use if
Contraindicated in patients with hypersensitivity to the drug or its components.
Side effects
Common adverse effects include neutropenia, thrombocytopenia, infections, bruising, and diarrhea.
Warnings
Monitor for bleeding, infections, cytopenias, and cardiac arrhythmias.
How it works
A Bruton's tyrosine kinase inhibitor that blocks B-cell signaling pathways.
Storage
Store at room temperature in the original container.
